United States · Platforms & data · Investing.com

Helus Pharma to present Phase 3 depression trial results Monday

Published by Investing.com · United States 2 h ago

Helus Pharma to present Phase 3 depression trial results Monday — Investing.com

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Andersen Group Inc. $ANDG Stock Sold by Royce & Associates LP

The Motley Fool

Is Interactive Brokers (IBKR) Stock a Buy After a 71% Dividend Increase?

India stands to gain as investors look beyond AI, Jefferies’ Wood says

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

How to Build $4,925 a Month in Tax-Free Dividend Income Inside a Roth IRA

Goldman Sachs’ calm 2027 forecast comes with a catch